TrialProstate cancer and prostatic diseases2022

A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND).

Michael R Harrison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.